syda-productions-shutterstock-com-2
Syda Productions / Shutterstock.com
5 May 2016AmericasTony Trippe

The world of gene editing patents

For more than 60 years researchers have explored gene therapy, now referred to as “gene editing”. Initial attempts in the 1950s utilised live vaccines to manipulate genetic sequences. More sophisticated methods began to emerge during the 1980s and early 1990s with endeavours to modify human DNA, including the first direct insertion of human DNA performed by French Anderson in September 1990.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
12 May 2026   The dominant player in the spatial biology market has sued a San Diego-based life sciences company over its genetic analysis technology, as another lawsuit in its patent litigation campaign approaches conclusion.
Americas
11 May 2026   Trade secret filings in the US reached an all-time high in 2025—particularly those relating to AI. Jeff Farrow of Michelman Robinson explains the principles that courts are increasingly applying, and how companies on both sides of the ‘v’ can prepare.
Americas
8 May 2026   LSIPR's senior reporter Marisa Woutersen speaks with Mythili Markowski of Regeneron on why new USPTO guidance is putting post-grant proceedings under the spotlight and how in-house teams are responding.